As described above, CACNA2D1 was shown to be consistently upregulated in the four selected publicly available bulk RNA-seq cohorts, three scRNA-seq datasets, and the previously established NPC cell lines. This evidence concerns the gene CACNA2D1 and nasopharyngeal carcinoma.